Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
ABL Bio Inc banner
A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 57 900 KRW -2.36% Market Closed
Market Cap: ₩3.2T
Write Note Create Alert Ask AI

Wall St Price Targets

Price Targets Summary
ABL Bio Inc

Wall Street analysts forecast ABL Bio Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABL Bio Inc is 265 200 KRW with a low forecast of 242 400 KRW and a high forecast of 294 000 KRW.

Lowest Forecast
Wall Street Target
₩242 400
319% Upside
Average Forecast
Wall Street Target
₩265 200
358% Upside
Highest Forecast
Wall Street Target
₩294 000
408% Upside
Lowest Forecast
Price Target
242 400 KRW
319% Upside
Average Forecast
Price Target
265 200 KRW
358% Upside
Highest Forecast
Price Target
294 000 KRW
408% Upside
ABL Bio Inc Competitors:
Price Targets

Revenue
Forecast

140% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss
140% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Over the last 8 years, the compound annual growth rate for Revenue has been 140%. The projected CAGR for the next 4 years is 25%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
41%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
41%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Continue Research

Summary
intrinsic value, competitors valuation, and company profile.
DCF Valuation
stock valuation using Discount Cash Flow valuation method.
Relative Valuation
stock valuation using valuation multiples.
Wall St Estimates
price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ABL Bio Inc's stock price target?
Price Target
265 200 KRW

According to Wall Street analysts, the average 1-year price target for ABL Bio Inc is 265 200 KRW with a low forecast of 242 400 KRW and a high forecast of 294 000 KRW.

What is the Revenue forecast for ABL Bio Inc?
Projected CAGR
25%

Over the last 8 years, the compound annual growth rate for Revenue has been 140%. The projected CAGR for the next 4 years is 25%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.